These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1155961)

  • 61. [Skin tests with phytohaemagglutinin (PHA). Correlation with other parameters of cell-mediated immunity (author's transl)].
    Breuer U; Strassburger D; Goerz G; Greither A
    Arch Dermatol Res (1975); 1976 Nov; 257(1):33-45. PubMed ID: 1008603
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cell-mediated immunity of patients who have had basal cell carcinomas.
    Czarnecki D; Mar A; Kulinskaya E
    Acta Derm Venereol; 1996 Jan; 76(1):28-30. PubMed ID: 8721486
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Abnormalities of quantitative dinitrochlorobenzene sensitization in cancer patients: correlation with tumor stage and histology.
    Catalona WJ; Chretien PB
    Cancer; 1973 Feb; 31(2):353-6. PubMed ID: 4687881
    [No Abstract]   [Full Text] [Related]  

  • 64. Effect of blood transfusion on the immune response of children with thalassaemia.
    Kanakoudi-Tsakalidis F; Spyroglou K; Tzafi R; Cassimos C
    Acta Haematol; 1977; 57(2):65-73. PubMed ID: 402767
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of mononuclear cells in the inflammatory infiltrates of cutaneous tumours.
    Viac J; Bustamante R; Thivolet J
    Br J Dermatol; 1977 Jul; 97(1):1-10. PubMed ID: 329852
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Impaired cell-mediated immunity of apparently normal patients who had multiple skin cancers.
    Czarnecki D; Zalcberg J; Kulinskáya E; Kay T
    Cancer; 1995 Jul; 76(2):228-31. PubMed ID: 8625096
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell-mediated immunity in epidermodysplasia verruciformis.
    Gliński W; Jablonska S; Langner A; Obalek S; Haftek M; Proniewska M
    Dermatologica; 1976; 153(4):218-27. PubMed ID: 1017532
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of viral and bacterial pneumonias on cell-mediated immunity in humans.
    Kauffman CA; Linnemann CC; Schiff GM; Phair JP
    Infect Immun; 1976 Jan; 13(1):78-83. PubMed ID: 1082445
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunotherapy for accessible tumors utilizing delayed hypersensitivity reactions and separated components of the immune system.
    Klein E; Holtermann O; Milgrom H; Case RW; Klein D; Rosner D; Djerassi I
    Med Clin North Am; 1976 May; 60(3):389-418. PubMed ID: 1271886
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cell-mediated immunity in professional and voluntary blood donors.
    Sharma MK; Anaraki F; Harbour C; Ala F
    Vox Sang; 1978; 35(5):350-3. PubMed ID: 358587
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A comparative study of a number of nutritional and immunological indices in patients with skin carcinoma.
    Moriarty M; O'Loughlin G; McFarlane R; Johnson A; Collins P; Mulgrew S; Conroy R; Daly L
    Ir J Med Sci; 1983 Jun; 152(6):242-5. PubMed ID: 6874293
    [No Abstract]   [Full Text] [Related]  

  • 72. Partial suppression of cell mediated immunity in chromoblastomycosis.
    Fuchs J; Pecher S
    Mycopathologia; 1992 Aug; 119(2):73-6. PubMed ID: 1435950
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Evaluation of cell-mediated immunity in the course of primary malignant tumors of the ovary. Cutaneous reactivity. (author's transl)].
    Gasparri F; Panconesi E; Periti P
    Tumori; 1975; 61(1):29-38. PubMed ID: 1226571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Diminished delayed hypersensitivity responses in the legs and feet of patients with endemic Kaposi's sarcoma.
    Ziegler JL; Katongole-Mbidde E
    Trans R Soc Trop Med Hyg; 1996; 90(2):173-4. PubMed ID: 8761581
    [No Abstract]   [Full Text] [Related]  

  • 75. Suppression of cellular immunity by anesthesia and operation.
    Tarpley JL; Twomey PL; Catalona WJ; Chretien PB
    J Surg Res; 1977 Mar; 22(3):195-201. PubMed ID: 839769
    [No Abstract]   [Full Text] [Related]  

  • 76. Intradermal antigen tests in psoriasis.
    McFadden JP; Powles AV; Baker BS; Valdimarsson H; Fry L
    Acta Derm Venereol; 1990; 70(3):262-4. PubMed ID: 1972847
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Cellular immune deficiency in black patients with basal cell carcinoma.
    Burns JE; Eisenhauer ED; Jabaley ME; Cruse JM
    J Surg Oncol; 1980; 13(2):129-34. PubMed ID: 6965744
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased lymphocyte blastogenic responses in patients with multiple basal cell carcinoma.
    Myskowski PL; Safai B; Good RA
    J Am Acad Dermatol; 1981 Jun; 4(6):711-4. PubMed ID: 7240477
    [No Abstract]   [Full Text] [Related]  

  • 79. The high incidence of Tinea pedis and unguium in patients with Kaposi's sarcoma.
    Alteras I; Cafri B; Feuerman EJ
    Mycopathologia; 1981 Jun; 74(3):177-9. PubMed ID: 6454847
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Immunity in tumours of the skin. Studies on cell-mediated immune reactions.
    Meneghini CL; Angelini G; Bonifazi E
    Arch Dermatol Forsch; 1975; 252(3):203-9. PubMed ID: 1155961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.